TMDX
TMDX
NASDAQ · Health Care

Transmedics Group Inc

$87.00
-1.07 (-1.21%)
Financial Highlights (FY 2026)
Revenue
519.33M
Net Income
163.21M
Gross Margin
59.9%
Profit Margin
31.4%
Rev Growth
+86.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 519.33M 278.58M 2.67B 2.60B
Gross Profit 311.18M 166.93M 1.10B 1.07B
Operating Income 93.12M 44.95M 215.76M 258.19M
Net Income 163.21M 78.79M 176.17M 221.55M
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Rev Growth +86.4% +86.4% -8.6% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 781.21M 781.21M 1.93B 1.88B
Total Equity 721.27M 721.27M 2.11B 1.74B
D/E Ratio 1.08 1.08 0.92 1.08
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 93.30M 47.55M 309.48M 247.18M
Free Cash Flow — — 251.22M 206.55M